• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.31 suppl.2

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.31 suppl.2"

Copied!
2
0
0

Texto

Loading

Referências

Documentos relacionados

Corticosteroid therapy in ARDS has been studied in three main different situations: 1) prevention in high risk patients (15,16), 2) early treatment with high-dose, short-course

High-dose Mel (1) followed by autologous stem cell transplantation (ASCT) has extensively been used in patients with multiple myeloma (MM), other lymphoid malignancies, such

Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceará-Brazil. Rev Bras

Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation..

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma

A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction

interaction between ACE-inhibitor high dose therapy and loop diuretic intensive therapy: patients taking enalapril or lisinopril at high dose (more than 10 mg and up to 30 mg per

Objective: To explore the impact on microvascular complications, long-term preser- vation of residual B-cell function and glycemic control of patients with type 1 diabetes